Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments, and Licenses (Tables)

v2.4.0.6
Acquisitions, Investments, and Licenses (Tables)
9 Months Ended
Sep. 30, 2012
Business Acquisition [Line Items]  
Maximum exposure of investments
                                     

(Dollars in thousands)

Investee Name

  Year Acquired    

Accounting Method

  Ownership
September 30,
2012
    Investment     Underlying
equity in net
assets
 

Sorrento

    2009     Equity method     19   $ 2,300     $ 1,596  

Cocrystal

    2009     Equity method     16     2,500       1,012  

Neovasc

    2011     Equity method, cost (warrants)     4     2,013       146  

Fabrus

    2010     VIE, equity method     13     650       53  

BZNE common stock

    2012     VIE, equity method     12     1,276       (9

Less: accumulated losses in investees

            (4,115        
                       

 

 

         

Total carrying value of equity method investees

            4,624          
                       

 

 

         

BZNE Note and conversion feature

    2012     VIE, investment available for sale     N/A       1,700          

ChromaDex

    2012     Investment, available for sale     1     1,000          

Neovasc options

    2011     Investment, available for sale     N/A       925          

TESARO

    2010     Investment, available for sale     2     731          

Plus: unrealized gains on investments, options and warrants, net

            6,018          
                       

 

 

         

Total carrying value of investments, available for sale

            10,374          
                       

 

 

         

Total

                      $ 14,998          
                       

 

 

         
ALS acquisition [Member]
 
Business Acquisition [Line Items]  
Estimated fair value of the net assets acquired and liabilities assumed at the dates of acquisition
         

(In thousands)

     

Current assets (includes cash of $230)

  $ 9,134  

Intangible assets:

       

Customer relationships

    436  

Technology

    5,437  

In-process research and development

    1,459  

Product registrations

    5,230  

Covenants not to compete

    187  

Tradename

    1,029  
   

 

 

 

Total intangible assets

    13,778  

Goodwill

    8,520  

Plant and equipment

    7,229  

Other assets

    611  

Accounts payable and accrued expenses

    (3,667

Deferred tax liability

    (3,169

Deferred payment

    (7,755

Debt assumed

    (7,829

Contingent consideration

    (1,197
   

 

 

 

Total purchase price

  $ 15,655  
   

 

 

 
FineTech acquisition [Member]
 
Business Acquisition [Line Items]  
Estimated fair value of the net assets acquired and liabilities assumed at the dates of acquisition
         

(In thousands)

     

Current assets (including cash of $2,000)

  $ 3,358  

Intangible assets:

       

Customer relationships

    14,200  

Technology

    2,700  

Covenants not to compete

    1,500  

Tradename

    400  
   

 

 

 

Total intangible assets

    18,800  

Goodwill

    11,623  

Plant and equipment

    1,358  

Other assets

    1,154  

Accounts payable and accrued expenses

    (910

Deferred tax liability

    (2,457

Contingent consideration

    (4,747
   

 

 

 

Total purchase price

  $ 28,179  
   

 

 

 
Claros Diagnostics acquisition [Member]
 
Business Acquisition [Line Items]  
Estimated fair value of the net assets acquired and liabilities assumed at the dates of acquisition
         

(In thousands)

     

Current assets (including cash of $351)

  $ 378  

Technology

    44,400  

Goodwill

    17,977  

Equipment

    333  

Other assets

    18  

Accounts payable and accrued expenses

    (655

Deferred tax liability

    (17,254

Contingent consideration

    (12,745
   

 

 

 

Total purchase price

  $ 32,452